The C-terminal domain of p21 inhibits nucleotide excision repair in vitro and in vivo

Molecular Biology of the Cell

Volumn 10, Issue 7, 1999, Pages 2119-2129

  Cooper, Marcus P ^a   Balajee, Adayabalam S ^a   Bohr, Vilhelm A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; DNA POLYMERASE; PROTEIN P21;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; DNA REPAIR; DNA REPLICATION; ENZYME INHIBITION; EXCISION REPAIR; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; PLASMID; PRIORITY JOURNAL; REGULATORY MECHANISM; ULTRAVIOLET IRRADIATION;

EID: 0032864677     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.7.2119     Document Type: Article

References (37)

1. Balajee, A.S., May, A., and Bohr, V.A. (1998). Fine structure analysis of DNA repair in mammalian cells. Mutat. Res. 404, 3-11.
2. Bohr, V.A., and Anson, R.M. (1995). DNA damage, mutation and fine structure DNA repair in aging. Mutat. Res. 338, 25-34.
3. Chen, J., Jackson, P.K., Kirschner, M.W., and Dutta, A. (1995). Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374, 386-388.
4. Chen, J., Peters, R., Saha, P., Lee, P., Theodoras, A., Pagano, M., Wagner, G., and Dutta, A. (1996). A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. Nucleic Acids Res. 24, 1727-1733.
5. Dent, G.A., Leglise, M.C., Pryzwansky, K.B., and Ross, D.W. (1989). Simultaneous paired analysis by flow cytometry of surface markers, cytoplasmic antigens, or oncogene expression with DNA content. Cytometry 10, 192-198.
6. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
7. CIP/WAF1 protein accumulation in head- and-neck cancer. Int. J. Cancer 74, 383-389.
8. Goubin, F., and Ducommun, B. (1995). Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10, 2281-2287.
9. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K., and Elledge, S.J. (1993). The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
10. Jackson, D.A., Balajee, A.S., Mullenders, L., and Cook, P.R. (1994). Sites in human nuclei where DNA damage by UV light is repaired: visualization and localization relative to the nucleoskeleton. J. Cell Sci. 107(Pt 7), 1745-1752.
11. Jackson, D.A., and Cook, P.R. (1986). A cell-cycle-dependent DNA polymerase activity that replicates intact DNA in chromatin. J. Mol. Biol. 192, 65-76.
12. Jackson, D.A., and Cook, P.R. (1988). A gentle method for preparing cyto- and nucleoskeletons and associated chromatin. J. Cell Sci. 90, 365-378.
13. Jackson, D.A., Hassan, A.B., and Cook, P.R. (1993). Visualization of focal sites of transcription within human nuclei. EMBO J. 22, 1059-1065.
14. Kuriyan, J., and O'Donnell, M. (1993). Sliding clamps of DNA polymerases. J. Mol. Biol. 234, 915-925.
15. Li, R., Hannon, G.J., Beach, D., and Stillman, B. (1996). Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6, 189-199.
16. Li, R., Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534-537.
17. Cip1. Nature 375, 159-161.
18. WAF/CIP1 -/-human cells. Cancer Res. 56, 2250-2255.
19. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98.
20. Pan, Z.-Q., Reardons, J.T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., and Hurwitz, J. (1995). Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J. Biol. Chem. 270, 22008-22016.
21. Podust, V.N., Podust, L.M., Goubin, F., Ducommun, B., and Hubscher, U. (1995). Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34, 8869-8875.
22. Prelich, G., Kostura, M., Maushak, D.R., Mathews, M.B., and Stillman, B. (1987). The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 326, 471-475.
23. Prelich, G., and Stillman, B. (1988). Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53, 117-126.
24. waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites. Oncogene 13, 1591-1598.
25. Sheikh, M.S., Carrier, F., Papathanasiou, M.A., Hollander, M.C., Zhan, Q., Yu, K., and Fornace, A.J.J. (1997). Identification of several human homologs of hamster DNA damage-inducible transcripts. Cloning and characterization of a novel UV-inducible cDNA that codes for a putative RNA-binding protein. J. Biol. Chem. 272, 26720-26726.
26. Shivji, M.K.K., Ferrari, E., Ball, K., Hubscher, U., and Wood, R.D. (1998). Resistance of human nucleotide excision repair synthesis in vitro to p21(Cdn1). Oncogene 27, 2827-2838.
27. Shivji, M.K.K., Gray, S.J., Strausfeld, U.P., Wood, R.D., and Blow, J.J. (1994). Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr. Biol. 4, 1062-1068.
28. Shivji, M.K.K., Kenny, M.K., and Wood, R.D. (1992). Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69, 367-374.
29. Trotter, M.J., Tang, L., and Tron, V.A. (1997). Overexpression of the cyclin-dependent kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma. J Cutaneous Pathol. 24, 265-271.
30. Tsurimoto, T., Melendy, T., and Stillman, B. (1990). Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature 346, 534-539.
31. Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
32. Warbrick, E., Lane, D.P., Glover, D.M., and Cox, L.S. (1995). A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5, 275-282.
33. Winegar, R., and Lutze, L.H. (1990). Introduction of biologically active proteins into viable cells by electroporation. Focus 22, 34-37.
34. Wood, R.D. (1996). DNA repair in eukaryotes. Annu. Rev. Biochem. 65, 135-167.
35. Wood, R.D., Robins, P., and Lindahl, T. (1988). Complementation of the Xeroderma pigmentosum DNA repair in cell-free extracts. Cell 53, 97-106.
36. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
37. Zhang, H., Xiong, Y., and Beach, D. (1993). Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4, 897-906.